U.S. markets closed

Heat Biologics, Inc. (HTBX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.47-0.11 (-1.67%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 4/14/2021
Current
12/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
170.25M121.10M194.71M92.72M44.42M
Enterprise Value 3
60.32M5.73M149.68M68.30M31.59M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
36.3214.2318.7610.196.22
Price/Book (mrq)
1.461.004.083.433.27
Enterprise Value/Revenue 3
20.469.49176.15115.1535.03
Enterprise Value/EBITDA 7
-2.45-0.84-16.98-17.46-6.13

Trading Information

Stock Price History

Beta (5Y Monthly) 0.32
52-Week Change 356.67%
S&P500 52-Week Change 347.72%
52 Week High 330.10
52 Week Low 33.50
50-Day Moving Average 37.81
200-Day Moving Average 37.69

Share Statistics

Avg Vol (3 month) 32.43M
Avg Vol (10 day) 3410.81k
Shares Outstanding 525.41M
Implied Shares Outstanding 6N/A
Float 24.28M
% Held by Insiders 14.15%
% Held by Institutions 111.31%
Shares Short (Mar 30, 2021) 42.37M
Short Ratio (Mar 30, 2021) 42.58
Short % of Float (Mar 30, 2021) 49.76%
Short % of Shares Outstanding (Mar 30, 2021) 49.33%
Shares Short (prior month Feb 25, 2021) 42.02M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 10, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:7
Last Split Date 3Dec 10, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-845.51%

Management Effectiveness

Return on Assets (ttm)-20.75%
Return on Equity (ttm)-41.01%

Income Statement

Revenue (ttm)2.95M
Revenue Per Share (ttm)0.18
Quarterly Revenue Growth (yoy)-69.80%
Gross Profit (ttm)-9.99M
EBITDA -24.59M
Net Income Avi to Common (ttm)-26.05M
Diluted EPS (ttm)-1.63
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)111.77M
Total Cash Per Share (mrq)4.4
Total Debt (mrq)1.85M
Total Debt/Equity (mrq)1.60
Current Ratio (mrq)31.12
Book Value Per Share (mrq)5.14

Cash Flow Statement

Operating Cash Flow (ttm)-22.02M
Levered Free Cash Flow (ttm)-15.67M